Capillary Technologies India's (NSE:CAPILLARY) Performance Is Even Better Than Its Earnings Suggest

Simply Wall St · 1d ago

Capillary Technologies India Limited (NSE:CAPILLARY) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that investors might be missing some promising details.

earnings-and-revenue-history
NSEI:CAPILLARY Earnings and Revenue History November 13th 2026

Zooming In On Capillary Technologies India's Earnings

Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. The ratio shows us how much a company's profit exceeds its FCF.

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.

Capillary Technologies India has an accrual ratio of -0.13 for the year to September 2026. Therefore, its statutory earnings were quite a lot less than its free cashflow. In fact, it had free cash flow of ₹1.4b in the last year, which was a lot more than its statutory profit of ₹637.2m. Capillary Technologies India shareholders are no doubt pleased that free cash flow improved over the last twelve months. However, that's not all there is to consider. The accrual ratio is reflecting the impact of unusual items on statutory profit, at least in part.

See our latest analysis for Capillary Technologies India

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

How Do Unusual Items Influence Profit?

Capillary Technologies India's profit was reduced by unusual items worth ₹69m in the last twelve months, and this helped it produce high cash conversion, as reflected by its unusual items. This is what you'd expect to see where a company has a non-cash charge reducing paper profits. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect Capillary Technologies India to produce a higher profit next year, all else being equal.

Our Take On Capillary Technologies India's Profit Performance

Considering both Capillary Technologies India's accrual ratio and its unusual items, we think its statutory earnings are unlikely to exaggerate the company's underlying earnings power. Looking at all these factors, we'd say that Capillary Technologies India's underlying earnings power is at least as good as the statutory numbers would make it seem. Obviously, we love to consider the historical data to inform our opinion of a company. But it can be really valuable to consider what other analysts are forecasting. Luckily, you can check out what analysts are forecasting by clicking here.

After our examination into the nature of Capillary Technologies India's profit, we've come away optimistic for the company. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.